|
Abstract: . . . achieved long-term. Additional anti-arrh y t h m i c therapy may be necessary if relapses occur after cardioversion. Management of permanent atrial fibrillation Haemodynamic impairment in AF results principally from an uncontrolled ventricular . . . . . . Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation . Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920. . . . . . . Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation . Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-920. . . . . . . immediately. If the duration is longer, or is unknown, anti-coagulant cover is necessary and cardioversion is deferred (see part 2). Direct current cardioversion requires a general anaesthesia or deep sedation, but is a low risk procedure provided the . . . --1081,4,135,1255,5406
|